Physician profile
Kyle Anderson
NPI 1770576332
$1,690.27
in general payments reported to CMS, 2019-2025
20 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $582 · 2020: $164 · 2021: $728 · 2022: $105 · 2024: $112.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $112.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $112.48 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $272.58 | 2019-2022 | |
| Pfizer INC. | $260.89 | 2019-2021 | |
| Abbvie INC. | $234.95 | 2021-2022 | |
| Novo Nordisk INC | $158.34 | 2019-2022 | |
| Tactile Systems Technology INC | $112.48 | 2024 | Entre Plus, Flexitouch Plus |
| Astellas Pharma US INC | $102.13 | 2019-2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $89.74 | 2019-2020 | |
| Amarin Pharma, INC. | $84.28 | 2019-2021 | |
| Amgen INC. | $68.06 | 2019-2021 | |
| Esperion Therapeutics, INC. | $56.06 | 2021 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $45.07 | 2021-2022 | |
| Abbott Laboratories | $37.49 | 2021 | |
| Janssen Pharmaceuticals, INC | $34.19 | 2019 | |
| Merck Sharp & Dohme LLC | $24.52 | 2019 | |
| Almatica Pharma LLC | $23.67 | 2021-2022 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bayer Healthcare Pharmaceuticals INC. | $19.07 | 2022 | |
| Lilly USA, LLC | $18.63 | 2021 | |
| Sanofi Pasteur INC. | $17.78 | 2019 | |
| Teva Pharmaceuticals USA, INC. | $16.88 | 2021 | |
| Biohaven Pharmaceuticals, INC. | $13.46 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kyle Anderson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.